VIVS — VivoSim Labs Income Statement
0.000.00%
Last trade - 00:00- $4.08m
- -$7.23m
- $0.14m
- 13
- 31
- 25
- 11
Annual income statement for VivoSim Labs, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 1.5 | 0.37 | 0.109 | 0.144 |
| Cost of Revenue | |||||
| Gross Profit | 0 | — | — | — | 0.139 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 16.8 | 13 | 18.1 | 15.2 | 12.8 |
| Operating Profit | -16.8 | -11.5 | -17.7 | -15.1 | -12.6 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -16.8 | -11.4 | -17.3 | -14.7 | -2.49 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -16.8 | -11.4 | -17.3 | -14.7 | -2.49 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -16.8 | -11.4 | -17.3 | -14.7 | -2.49 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -16.8 | -11.4 | -17.3 | -14.7 | -2.49 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.17 | -1.32 | -1.98 | -1.6 | -6.14 |